NEOG

Neogen

Healthcare Medical Devices NASDAQ

About the company

Neogen Corporation, a leading company in the field of food and animal safety, is headquartered in Lansing, Michigan. With a rich history of developing, manufacturing, and marketing innovative products, Neogen has established itself as a trusted provider of solutions for global food and feed processing companies. One of Neogen's primary focuses is food safety, which accounts for a significant portion of its post-merger sales, about 70%. With a strong commitment to ensuring the quality and integrity of food, Neogen specializes in diagnostic tools that help detect unintended substances in food and animal feed. These substances include pathogens, allergens, and drug residues that could potentially pose risks to human health. By detecting and identifying these contaminants, Neogen plays a crucial role in preventing outbreaks of foodborne illnesses and improving the overall safety of the food supply chain. In addition to its food safety division, Neogen also dedicates its efforts to animal safety. This segment contributes about 20% of Neogen's post-merger sales. The company offers a wide range of products, including veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for a variety of animals, such as cattle, horses, and canines. Neogen's animal safety products help safeguard the health and well-being of livestock and companion animals, ensuring the highest standards of care and protection. Neogen's operations span across various geographical regions. The United States accounts for 60% of its total revenue, reflecting the company's strong presence and market leadership in its home country. However, Neogen has also successfully expanded its footprint worldwide, with international markets contributing 40% of its revenue. Its global reach extends to countries such as Canada, Europe, Asia, and Latin America, enabling Neogen to address the specific needs and requirements of diverse markets. With its cutting-edge technology, extensive product portfolio, and commitment to safety and quality, Neogen continues to be at the forefront of innovation in the food and animal safety industry. The company's ongoing dedication to research and development ensures that it stays ahead of emerging threats and provides effective solutions for its customers. Neogen's unwavering focus on food and animal safety underscores its mission to protect and enhance the well-being of both humans and animals around the world.

Website: https://www.neogen.com

Data updated: June 10, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1345 peers in sector

Metric NEOG Sector median Vs. industry
P/E - 20.13
EPS -2.80 USD -1.14 USD ↓ Below average
Dividend yield 0.00% 0.00%
Profit margin -69.94% 0.00% ↓ Below average
ROE -25.57% -58.89% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Neogen?
Neogen Corporation, a leading company in the field of food and animal safety, is headquartered in Lansing, Michigan. With a rich history of developing, manufacturing, and marketing innovative products, Neogen has established itself as a trusted provider of solutions for global food and feed processing companies. One of Neogen's primary focuses is food safety, which accounts for a significant portion of its post-merger sales, about 70%. With a strong commitment to ensuring the quality and integrity of food, Neogen specializes in diagnostic tools that help detect unintended substances in food and animal feed. These substances include pathogens, allergens, and drug residues that could potentially pose risks to human health. By detecting and identifying these contaminants, Neogen plays a crucial role in preventing outbreaks of foodborne illnesses and improving the overall safety of the food supply chain. In addition to its food safety division, Neogen also dedicates its efforts to animal safety. This segment contributes about 20% of Neogen's post-merger sales. The company offers a wide range of products, including veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for a variety of animals, such as cattle, horses, and canines. Neogen's animal safety products help safeguard the health and well-being of livestock and companion animals, ensuring the highest standards of care and protection. Neogen's operations span across various geographical regions. The United States accounts for 60% of its total revenue, reflecting the company's strong presence and market leadership in its home country. However, Neogen has also successfully expanded its footprint worldwide, with international markets contributing 40% of its revenue. Its global reach extends to countries such as Canada, Europe, Asia, and Latin America, enabling Neogen to address the specific needs and requirements of diverse markets. With its cutting-edge technology, extensive product portfolio, and commitment to safety and quality, Neogen continues to be at the forefront of innovation in the food and animal safety industry. The company's ongoing dedication to research and development ensures that it stays ahead of emerging threats and provides effective solutions for its customers. Neogen's unwavering focus on food and animal safety underscores its mission to protect and enhance the well-being of both humans and animals around the world.
How big is Neogen?
The market capitalization of Neogen — the combined value of all its shares — is 1.97 B USD. The higher the market cap, the larger the company. (as of 2026-06-10)
Does Neogen pay dividends?
The dividend yield of Neogen is 0.00% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-10)
What sector does Neogen belong to?
Neogen operates in the Healthcare sector, industry: Medical Devices.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120